Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2012 Oct 13;19(1 0):S38–S43. doi: 10.1016/j.bbmt.2012.10.003

Figure 2.

Figure 2

Figure 2

A Lymphoma Cell Therapy Consortium. Geographical map of core sites and collaborating centers.

B Treatment Schema: Reduced Intensity Conditioning (RIC) and Allogeneic Stem Cell Transplantation (AlloSCT) Followed by Latent Membrane Protein (LMP) Specific-Cytotoxic T cell Lymphocytes (CTLs) in Patients with Epstein Barr Virus (EBV) Positive Refractory/Recurrent Hodgkin Lymphoma (HL)